Literatur
- 1
Ahlman H.
Surgical treatment of carcinoid tumours of the stomach and
small intestine.
Ital J Gastroenterol
Hepatol.
1999;
31
(Suppl
2)
198-201
- 2
Arnold R, Simon B, Wied M.
Treatment of neuroendocrine GEP tumours with somatostatin
analogues: a
review.
Digestion.
2000;
62
(Suppl
1)
84-91
- 3
Capella C. et al .
Revised classification of neuroendocrine tumors of the lung,
pancreas and
gut.
Digestion.
1994;
55
11-23
(Suppl
3)
- 4
Eriksson B, Öberg K, Stridsberg M.
Tumor markers in neuroendocrine
tumors.
Digestion.
2000;
62
(Suppl
1)
33-38
- 5
Faiss S, Pape U, Böhmig M. et al .
Prospective, randomized multicenter trial on the
antiproliferative effect of lanreotide, interferon-alpha and their combination
for therapy of metastatic neuroendocrine gastroenteropancreatic
tumors.
J Clin Oncol.
2003;
im
Druck
- 6
Kirchhoff T. et al .
Chemoembolization of hepatic metastases from intestinal
neuroendocrine tumours.
Eur J Gastroenterol
Hepatol.
2000;
12
141-143
- 7
Modlin I M, Sandor A.
An analysis of 8305 cases of carcinoid
tumors.
Cancer.
1997;
79
813-829
- 8
Norton J A, Fraker D L, Alexander H R. et al .
Surgery to cure the Zollinger-Ellison syndrome.
N
Engl J
Med.
1999;
341
635-644
- 9
Öberg K.
Chemotherapy and biotherapy in the treatment of
neuroendocrine tumours.
Ann
Oncol.
2001;
12
(Suppl
2)
111-114
- 10
Rougier P, Mitry E.
Chemotherapy in the treatment of neuroendocrine malignant
tumors.
Digestion.
2000;
62
(Suppl
1)
73-78
- 11
Scherübl H. et al .
Neuroendocrine tumors of the gastroenteropancreatic
system.
Onkologie.
1996;
19
119-124
und 214 - 219
- 12
Spitzweg C, Göke B.
Therapie endokriner gastrointestinaler
Tumoren.
Internist.
2002;
43
219-229
Priv.-Doz. Dr. H. Scherübl
Medizinische Klinik I, Universitätsklinikum Benjamin
Franklin, Freie Universität Berlin
Hindenburgdamm 30
12200 Berlin
Phone: +49/30/84453534
Fax: +49/30/84454481
Email: hans.scheruebl@medizin.fu-berlin.de
